FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2026
Voltar para busca
Dado oficial do USPTO
DINGGUI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
25/01/2024
Data de registro
20/05/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/05/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
STRUCK, ROBERT J
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "DINGGUI" in red and outlined in black, yellow, and orange.
Titulares e representantes
Titulares
YABAO PHARMACEUTICAL GROUP CO., LTD.
Representantes
He Li FIDELI LAW PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Preparations for the treatment of asthma; medical preparations and drugs for the treatment of respiratory system diseases and disorders; medicated lip balm; decoctions for pharmaceutical purposes for the treatment of respiratory system diseases and disorders; medicinal formulations for skin woundspharmaceutical preparations for skin wounds; medicinal formulations for treating bone fracturespharmaceutical preparations for the treatment of bone fractures; paracetamol; anti-inflammatories; antidiarrheal medicines; pharmaceutical preparations for treating asthma; anti-allergy medications; antiviral preparations; pharmaceuticals for treating viral diseases; pharmaceutical preparations for treating allergies; bulk medicine used for treating cardiovascular and cerebrovascular diseases; vitamin supplement tablets; cough suppressant and phlegm relieverscough treatment preparations; injectable medications for allergic reactions; mosquito repellent patch for babies; medicated baby powder; fever reduceribuprofen; antiemetic drugsnausea treatment preparations; cough suppressantscough expectorants; mosquito repellents for use on the skin; preparations for the treatment of heatstroke; anti-inflammatory spray; traditional Chinese medicinal herb preparations; cough drops; pain relief medications; chemotherapeutic drugspharmaceutical preparations for use in chemotherapy; antibiotic for humans; medicated ointment for the treatment of dermatological conditions; ointment for treatment of skin diseases; medicated baby oil; ophthalmic pharmaceutical preparations; migraine treatment preparations; balsamic preparations for medical purposes; cough syrup for medical use; dermatological pharmaceuticals; anti-inflammatory preparations; expectorants; pharmaceutical preparations in the form of tablets for treating cardiovascular and cerebrovascular diseases; disinfectants; fever and pain relieversibuprofen; anticoagulants; anti-inflammatory ointments; oral ibuprofen for pain relief; injectable pharmaceutical preparations for treating cardiovascular and cerebrovascular diseases; injectable dermal fillers; powdered milk for babies; lutein dietary supplements; dietetic foods adapted for medical use; medicated candies; lecithin dietary supplements; mineral dietary supplements; dietetic beverages adapted for medical use; dietetic foods adapted for medical purposes; baby cookiesbaby food; zinc dietary supplement; infant formula; lacteal flour for babies; dietetic beverages adapted for medical purposes; nutritional supplements; candy for pharmaceutical purpose for the treatment of respiratory system diseases and disorders; food for babies; milk sugar for pharmaceutical purposes; dietetic candies adapted for medical purposes; vitamin beverages adapted for medical purposes; casein dietary supplements; liquid formula for infants; linseed oil dietary supplements; protein dietary supplements; disposable baby diapers; baby swim diapers; diaper changing matsdisposablefor babies; disposable swim diapers for toddlers and infants; swim diapersdisposablefor babies; bandages for dressings; medical dressing; adhesive plasters for medical purposes; swim diapersreusablefor babies
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/12/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/12/2025
FIMP
FINAL DISPOSITION PROCESSED
19/12/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
20/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2025
PUBO
PUBLISHED FOR OPPOSITION
01/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/03/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
21/02/2025
ALIE
ASSIGNED TO LIE
21/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
21/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/01/2025
RFNT
REFUSAL PROCESSED BY IB
15/09/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/08/2024
RFRR
REFUSAL PROCESSED BY MPU
26/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/08/2024
CNRT
NON-FINAL ACTION WRITTEN
20/08/2024
DOCK
ASSIGNED TO EXAMINER
20/08/2024
MAFR
APPLICATION FILING RECEIPT MAILED
31/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/07/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/07/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DINGGUI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.